Skip to main content
. 2020 Apr;8(7):441. doi: 10.21037/atm.2020.03.190

Table 3. Univariate analysis and multivariate analysis the association of different variables with disease-free survival.

Variables Univariate analysis Multivariate analysis
HR (95% CI) P value Adjusted HR (95% CI) P value
Leukocytosis 1.544 (1.282, 1.859) <0.001 1.417 (1.176, 1.707) <0.001
Gender (male) 1.339 (1.151, 1.594) 0.001 0.961 (0.696, 1.381) 0.705
Age (≥65 years) 0.816 (0.535, 1.192) 0.167 NA
Tumor depth (T3–T4) 3.046 (2.758, 3.364) <0.001 2.635 (1.658, 3.713) <0.001
Lymph node metastasis (N2–N3) 4.506 (4.050, 5.014) <0.001 2.655 (2.287, 3.083) <0.001
Tumor stage (III–IV) 6.401 (5.735, 7.144) <0.001 5.352 (4.593, 6.236) <0.001
Tumor location (middle) 0.872 (0.650, 1.025) 0.375 NA
Tumor type (adenocarcinoma) 1.057 (0.754, 1.385) 0.653 NA
Tumor differentiation (poor) 1.575 (1.057, 2.068) 0.021 2.015 (1.604, 2.547) <0.001
Surgical procedure (open) 4.051 (3.137, 4.934) <0.001 2.304 (1.486, 3.211) <0.001
Postoperative chemotherapy (no) 4.237 (3.248, 5.134) <0.001 1.341 (1.124, 1.567) 0.012
Anesthesia (general and epidural) 0.848 (0.346, 1.331) 0.891 NA
Number of incisions [2] 1.021 (0.761, 1.314) 0.549 NA